» Articles » PMID: 24062612

Oxidized LDL Induces Alternative Macrophage Phenotype Through Activation of CD36 and PAFR

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2013 Sep 25
PMID 24062612
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

OxLDL is recognized by macrophage scavenger receptors, including CD36; we have recently found that Platelet-Activating Factor Receptor (PAFR) is also involved. Since PAFR in macrophages is associated with suppressor function, we examined the effect of oxLDL on macrophage phenotype. It was found that the presence of oxLDL during macrophage differentiation induced high mRNA levels to IL-10, mannose receptor, PPAR γ and arginase-1 and low levels of IL-12 and iNOS. When human THP-1 macrophages were pre-treated with oxLDL then stimulated with LPS, the production of IL-10 and TGF- β significantly increased, whereas that of IL-6 and IL-8 decreased. In murine TG-elicited macrophages, this protocol significantly reduced NO, iNOS and COX2 expression. Thus, oxLDL induced macrophage differentiation and activation towards the alternatively activated M2-phenotype. In murine macrophages, oxLDL induced TGF- β , arginase-1 and IL-10 mRNA expression, which were significantly reduced by pre-treatment with PAFR antagonists (WEB and CV) or with antibodies to CD36. The mRNA expression of IL-12, RANTES and CXCL2 were not affected. We showed that this profile of macrophage activation is dependent on the engagement of both CD36 and PAFR. We conclude that oxLDL induces alternative macrophage activation by mechanisms involving CD36 and PAFR.

Citing Articles

Aberrant mitochondrial DNA synthesis in macrophages exacerbates inflammation and atherosclerosis.

Natarajan N, Florentin J, Johny E, Xiao H, ONeil S, Lei L Nat Commun. 2024; 15(1):7337.

PMID: 39187565 PMC: 11347661. DOI: 10.1038/s41467-024-51780-1.


CD36/Lyn kinase interactions within macrophages promotes pulmonary fibrosis in response to oxidized phospholipid.

Kwak D, Bradley P, Subbotina N, Ling S, Teitz-Tennenbaum S, Osterholzer J Respir Res. 2023; 24(1):314.

PMID: 38098035 PMC: 10722854. DOI: 10.1186/s12931-023-02629-6.


HDL and LDL have distinct, opposing effects on LPS-induced brain inflammation.

Radford-Smith D, Yates A, Rizvi L, Anthony D, Probert F Lipids Health Dis. 2023; 22(1):54.

PMID: 37095493 PMC: 10124044. DOI: 10.1186/s12944-023-01817-z.


Cellular FXIII in Human Macrophage-Derived Foam Cells.

Somodi L, Horvath E, Bardos H, Barath B, Petho D, Katona E Int J Mol Sci. 2023; 24(5).

PMID: 36902231 PMC: 10002485. DOI: 10.3390/ijms24054802.


Hyperlipidemia in tendon injury: chronicles of low-density lipoproteins.

Fang W, Bonavida V, Agrawal D, Thankam F Cell Tissue Res. 2023; 392(2):431-442.

PMID: 36738312 PMC: 10172214. DOI: 10.1007/s00441-023-03748-8.


References
1.
Rios F, Jancar S, Melo I, Ketelhuth D, Gidlund M . Role of PPAR-gamma in the modulation of CD36 and FcgammaRII induced by LDL with low and high degrees of oxidation during the differentiation of the monocytic THP-1 cell line. Cell Physiol Biochem. 2008; 22(5-6):549-56. DOI: 10.1159/000185539. View

2.
Duenas A, Aceves M, Fernandez-Pisonero I, Gomez C, Orduna A, Sanchez Crespo M . Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate. Cardiovasc Res. 2008; 79(3):537-44. DOI: 10.1093/cvr/cvn087. View

3.
Walton K, Cole A, Yeh M, Subbanagounder G, Krutzik S, Modlin R . Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler Thromb Vasc Biol. 2003; 23(7):1197-203. DOI: 10.1161/01.ATV.0000079340.80744.B8. View

4.
Bouhlel M, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S . PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 2007; 6(2):137-43. DOI: 10.1016/j.cmet.2007.06.010. View

5.
Ryoo S, Lemmon C, Soucy K, Gupta G, White A, Nyhan D . Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circ Res. 2006; 99(9):951-60. DOI: 10.1161/01.RES.0000247034.24662.b4. View